Synthesis and Cytotoxic Activity of Ethyl 2-Amino-1-Benzamido-4-Oxo-5-(2-Oxo-2-Arylethylidene)- 4,5-Dihydro-1H-Pyrrole-3-Carboxylates
- 作者: Zykova S.S.1, Galembikova A.R.2, Ramazanov B.R.2, Odegova T.F.3, Igidov N.M.3, Kiselev M.A.3, Boichuk S.V.2
- 
							隶属关系: 
							- Perm Federal Penal Service Institute
- Kazan State Medical University
- Perm State Pharmaceutical Academy
 
- 期: 卷 49, 编号 12 (2016)
- 页面: 817-820
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244299
- DOI: https://doi.org/10.1007/s11094-016-1378-1
- ID: 244299
如何引用文章
详细
Recyclization of 5-aryl-2,3-dihydro-2-furandione 3-benzoylhydrazones (I) induced by cyanoacetic ester produced ethyl 2-amino-1-benzamido-4-oxo-5-(2-oxo-2-arylethylidene)-4,5-dihydro-1H-pyrrole-3-carboxylates (IIa-g). The biological activity of the synthesized compounds, which possessed low toxicities, was investigated. Ethyl 2-amino-1-benzamido-5-[2-(4-chlorophenyl)-2-oxoethylidene]-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylate (IIf) and the 5-[2-(3,4-dimethoxyphenyl)-2-oxoethylidene] analog (IIc) exhibited the greatest cytotoxicities against several connective-tissue tumor cell lines, namely, gastrointestinal stromal tumors (GISTs), osteosarcoma U2OS, and leiomyosarcoma SK-LMS-1. Ethyl 2-amino-1-benzamido-4-oxo-5-[2-oxo-2-(p-tolyl)ethylidene]-4,5-dihydro-1H-pyrrole-3-carboxylate (IIa) suppressed significantly tumor growth of GIST, LMS, and OS cell lines. Its activity against GIST cells at 10 μM was comparable with that of imatinib (1 μM) and, at lower concentrations (2.5 and 5 μM), with those of doxorubicin (0.25 μg/mL) and etoposide (40 μM), and exceeded significantly those of taxol (1 μM) and hydroxyurea (1 mM). The cytotoxicities of most of the studied compounds at 10 μM against SK-LMS-1 and U2OS cells in vitro were significantly greater than all reference drugs (doxorubicin, taxol, etoposide, etc.).
作者简介
S. Zykova
Perm Federal Penal Service Institute
							编辑信件的主要联系方式.
							Email: zykova.sv@rambler.ru
				                					                																			                												                	俄罗斯联邦, 							125 Karpinskogo St., Perm, 614012						
A. Galembikova
Kazan State Medical University
														Email: zykova.sv@rambler.ru
				                					                																			                												                	俄罗斯联邦, 							49 Butlerova St., Kazan, Tatarstan, 420012						
B. Ramazanov
Kazan State Medical University
														Email: zykova.sv@rambler.ru
				                					                																			                												                	俄罗斯联邦, 							49 Butlerova St., Kazan, Tatarstan, 420012						
T. Odegova
Perm State Pharmaceutical Academy
														Email: zykova.sv@rambler.ru
				                					                																			                												                	俄罗斯联邦, 							2 Polevaya St., Perm, 614009						
N. Igidov
Perm State Pharmaceutical Academy
														Email: zykova.sv@rambler.ru
				                					                																			                												                	俄罗斯联邦, 							2 Polevaya St., Perm, 614009						
M. Kiselev
Perm State Pharmaceutical Academy
														Email: zykova.sv@rambler.ru
				                					                																			                												                	俄罗斯联邦, 							2 Polevaya St., Perm, 614009						
S. Boichuk
Kazan State Medical University
														Email: zykova.sv@rambler.ru
				                					                																			                												                	俄罗斯联邦, 							49 Butlerova St., Kazan, Tatarstan, 420012						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					